SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-17-020602
Filing Date
2017-08-17
Accepted
2017-08-17 16:19:45
Documents
1
Period of Report
2017-08-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3960
  Complete submission text file 0000899243-17-020602.txt   5632
Mailing Address 8 CROSS STREET #10-00 SINGAPORE U0 048424
Business Address 8 CROSS STREET #10-00 SINGAPORE U0 048424 617-206-4830
Wave Life Sciences Ltd. (Issuer) CIK: 0001631574 (see all company filings)

IRS No.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O WAVE LIFE SCIENCES LTD. 733 CONCORD AVE. CAMBRIDGE MA 02138
Business Address
TAKANASHI KEN (Reporting) CIK: 0001657768 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37627 | Film No.: 171038849